Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care
Completed
15 and under
Other
2006-02-069
NCT00336531
Last Modified:
7/11/2007
 
First Published:
6/1/1999
2.
Phase III Randomized Study of Itraconazole Versus Fluconazole to Prevent Asgergillus Infections in Patients Undergoing Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation (Summary Last Modified 10/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
13 and over
NCI
FHCRC-1322.00
NCI-H99-0030, NCT00003883
3.
Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)(COMPLETED)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Completed
13 and over
Pharmaceutical / Industry
P01899
NCT00044486
Last Modified:
1/16/2008
 
First Published:
9/1/2002
4.
Phase I/II Study of PKC412 With or Without Itraconazole in Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
MSKCC-02021
NOVARTIS-CPKC412A2104, NCI-G02-2107, UCLA-0305058-01, NCT00045578
Last Modified:
9/1/1992
5.
An Open, Multicenter, Comparative Study of the Efficacy, Safety, and Tolerance of Fluconazole vs Itraconazole in the Treatment of Cancer Patients with Oropharyngeal Candidiasis (Summary Last Modified 09/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
16 and over
EORTC-19911
Last Modified:
7/12/2007
 
First Published:
2/20/2004
6.
Randomized Study of Voriconazole Versus Itraconazole for the Prevention of Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
12 and over
NCI
UCLA-0307071
NCT00079222
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute